Philippines -
anglais -
FDA (Food And Drug Administration)
suigen prdc formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein suspension for injection (im)
virbac philippines inc.; distributor: virbac philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , mycoplasma hyopneumoniae , streptococcus suis , haemophilus parasuis vaccine (vet.) - suspension for injection (im) - formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein
Philippines -
anglais -
FDA (Food And Drug Administration)
suigen app+pm formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae type 1, 2 and 5 ....... >10^ 9.2 cfu before inactivation pasteurella multocida, type d (pm-18 strain) ......... >10^ 9.2 cfu before inactivation cfu - colony forming unit suspension for injection (im)
virbac phillippines inc. - inactivated actinobacillus pleuropneumoniae , pasteurella multocida vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae type 1, 2 and 5 ....... >10^ 9.2 cfu before inactivation pasteurella multocida, type d (pm-18 strain) ......... >10^ 9.2 cfu before inactivation cfu - colony forming unit
Philippines -
anglais -
FDA (Food And Drug Administration)
rhiniseng formulation: each 2 ml (dose) contains: bordetella bronchiseptica (strain 833 cer).....................2 x 100 corresponding to 9.8 bbcc pasteurella multocida toxin (type d)...........................110 ug inducing >i med63 bordetella bronchiseptica cell count (bbcc) murine effective dose 63 (med) suspension for injection (im)
hipra philippines inc.; distributor: hipra philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida toxin vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (strain 833 cer).....................2 x 100 corresponding to 9.8 bbcc pasteurella multocida toxin (type d)...........................110 ug inducing >i med63 bordetella bronchiseptica cell count (bbcc) murine effective dose 63 (med)
Philippines -
anglais -
FDA (Food And Drug Administration)
pm-onevax-c formulation: each 0.01 ml (dose) contains: pasteurella multocida (pm-1 strain) ..... >17.6 x 10^7 cfu cfu - colony forming unit freeze-dried powder for injection (wing web)
msd animal health (phils.), inc. - live avirulent pasteurella multocida vaccine (vet.) - freeze-dried powder for injection (wing web) - formulation: each 0.01 ml (dose) contains: pasteurella multocida (pm-1 strain) ..... >17.6 x 10^7 cfu cfu - colony forming unit
Philippines -
anglais -
FDA (Food And Drug Administration)
suishot apm-7 each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit suspension for injection (im)
agrimate, inc.; distributor: agrimate, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae toxoid vaccine (vet.) - suspension for injection (im) - each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit
Philippines -
anglais -
FDA (Food And Drug Administration)
avipro 108. fc3 platinum formulation: each 0.25 ml (dose) contains: pasteurella multocida, type 1 (x-73 strain) .........> 10^8.5 cfu , type 4 (p-1662 strain)..................> 10^8.5 cfu , type 3x4 (86-1913 strain) ....................> 10^8.5 cfu cfu - colony forming unit emulsion for injection (sc/im)
elanco philippines, inc.; distributor: elanco philippines, inc. - inactivated pasteurella multocida vaccine (vet.) - emulsion for injection (sc/im) - formulation: each 0.25 ml (dose) contains: pasteurella multocida, type 1 (x-73 strain) .........> 10^8.5 cfu , type 4 (p-1662 strain)..................> 10^8.5 cfu , type 3x4 (86-1913 strain) ....................> 10^8.5 cfu cfu - colony forming unit
Philippines -
anglais -
FDA (Food And Drug Administration)
aradicator formulation: each 2 ml (dose) contains: bordetella bronchiseptica (2-9 nadl strain)................ >1.8 ou pasteurella multocida (type d) (strain 8).................. >4.0 cellsou pasteurella multocida (type d) (strain 8)............... > 175 toxoid ru . ru-relative units ou-opacity units suspension for injection (im)
zoetis philippines inc.; distributor: zoetis philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocidạ vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (2-9 nadl strain)................ >1.8 ou pasteurella multocida (type d) (strain 8).................. >4.0 cellsou pasteurella multocida (type d) (strain 8)............... > 175 toxoid ru . ru-relative units ou-opacity units
Philippines -
anglais -
FDA (Food And Drug Administration)
rhiniffa t formulation: each 2 ml (dose) contains: bordetella bronchiseptica (372cn strain) ...... ......... >0.9 sa unit pasteurella multocida (m17 strain) ...................... >0.9 elisa unit pasteurella multocida (m17 strain) toxoid.............. >1 elisa unit sa - seroagglutinating unit to obtain 1 log 10 seroagglutinating antibodies in laboratory animals elisa - enzyme-linked immunosorbent assay unit to obtain 1 log10 seroagglutinating antibodies in laboratory animals suspension for injection (im)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated bordetella bronchiseptica , pasteurella multocida vaccine (vet.) : - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (372cn strain) ...... ......... >0.9 sa unit pasteurella multocida (m17 strain) ...................... >0.9 elisa unit pasteurella multocida (m17 strain) toxoid.............. >1 elisa unit sa - seroagglutinating unit to obtain 1 log 10 seroagglutinating antibodies in laboratory animals elisa - enzyme-linked immunosorbent assay unit to obtain 1 log10 seroagglutinating antibodies in laboratory animals
Philippines -
anglais -
FDA (Food And Drug Administration)
res-vac formulation: each 2 ml (dose) contains: bordetella bronchiseptica (bb1 strain) ... 21.5 x 1010 cfu bordetella bronchiseptica toxoid ....... .............. 500 ug pasteurella multocida, type a and d..... ....... 21.5 x 1010 cfu pasteurella multocida type d toxoid ............... 500 ug actinobacillus pleuropneumoniae, type 2 and 5 ................. ..... 21 x 1010 cfu actinobacillus pleuropneumoniae, type 2 and 5 toxoid .......... ................ 100 ug glaesserella parasuis, type 4 and 5 ........... ........ 24 x 10°cfu mesomycoplasma hyopneumoniae (j101 strain) .............. ........ 22 x 108 cfu cfu - colony forming unit suspension for injection (im)
nobel vet, inc.; distributor: nobel vet, inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , glaesserella parasuis , mesomycoplasma hyopneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (bb1 strain) ... 21.5 x 1010 cfu bordetella bronchiseptica toxoid ....... .............. 500 ug pasteurella multocida, type a and d..... ....... 21.5 x 1010 cfu pasteurella multocida type d toxoid ............... 500 ug actinobacillus pleuropneumoniae, type 2 and 5 ................. ..... 21 x 1010 cfu actinobacillus pleuropneumoniae, type 2 and 5 toxoid .......... ................ 100 ug glaesserella parasuis, type 4 and 5 ........... ........ 24 x 10°cfu mesomycoplasma hyopneumoniae (j101 strain) .............. ........ 22 x 108 cfu cfu - colony forming unit
Philippines -
anglais -
FDA (Food And Drug Administration)
rhinisin dnt formulation: each dose (2 ml) contains: pasteurella multocida (115/a strain)................10^10 - 10^11 cfu pasteurella multocida (type d dermonecrotoxic toxoid)....... 2-4 ug bordetella bronchiseptica (strain 6230)........... .......... 10^10 - 10^11 cfu cfu - colony forming unit emulsion for injection (im)
broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - inactivated pasteurella multocida , bordetella bronchiseptica toxoid vaccine (vet.) - emulsion for injection (im) - formulation: each dose (2 ml) contains: pasteurella multocida (115/a strain)................10^10 - 10^11 cfu pasteurella multocida (type d dermonecrotoxic toxoid)....... 2-4 ug bordetella bronchiseptica (strain 6230)........... .......... 10^10 - 10^11 cfu cfu - colony forming unit